FIELD: pharmacology.
SUBSTANCE: composition contains an effective amount of the soluble part of whole-cell drug Mycoplasma m.hyopneumoniae (M.hyo); where the soluble part of the whole-cell drug M.hyo contains M.hyo-specific soluble protein antigens and is separated from the insoluble cell bulk, and is essentially free from both (i) lg (G), and (ii) immunocomplexes, consisting of an antigen attached to immunoglobulin.
EFFECT: induction of an immune response in a subject against the aforementioned disease.
13 cl, 10 dwg, 14 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
| COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
| METHODS AND COMPOSITIONS FOR IMMUNISATION OF PIGS AGAINST PORCINE CIRCOVIRUS | 2008 |
|
RU2493254C9 |
| INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
| PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
| COMBINED VACCINE FOR INTRADERMAL ADMINISTRATION | 2020 |
|
RU2835620C1 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| COMBINATION OF VACCINES FOR PREVENTIVE TREATMENT OF SWINE | 2021 |
|
RU2834834C1 |
